HCPCS Code Descriptor:
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
50474-0710-81, 50474-0710-79, 50474-0700-62
Route of Administration:
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
CIMZIA is an Immunology:Anti-TNF drug manufactured by UCB and administered via the Subcutaneous route of administration. The J Code: J0717 is aligned to the drug CIMZIA.
Access Pricing and More By Registering
HCPCS Added Date:
HCPCS Effective Date:
HCPCS Short Description:
Certolizumab pegol inj 1mg
Billing and Coding Guide: